FDA Adverse Event Injury Summary report: N

NEXGEN FEMORAL AUGMENTS

MDR report key: 7240013 · Received February 4, 2018

Report

Report Number
0001822565-2018-00508
Event Type
Injury
Date Received
February 4, 2018
Date of Event
January 9, 2018
Report Date
June 19, 2018
Manufacturer
ZIMMER BIOMET, INC.
Product Code
JWH
PMA / PMN Number
PK946150
Removal / Correction Number
N/A
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

UPON REASSESSMENT OF THE REPORTED EVENT, IT WAS DETERMINED THAT THIS DEVICE WAS NOT INVOLVED IN THE EVENT. THE INITIAL REPORT WAS SUBMITTED IN ERROR AND SHOULD BE VOIDED.

Additional Manufacturer Narrative · 1

(B)(4). CONCOMITANT MEDICAL PRODUCTS: NEXGEN ROTATING HINGE KNEE FEMORAL COMPONENT CAT#: 00588001501, LOT#: 61511043, NEXGEN FEMORAL AUGMENTS CAT#: 00599003510, LOT#: 61338227, NEXGEN STEM EXTENSION CAT#: 00598801112, LOT#: 60592147, NEXGEN FEMORAL AUGMENTS CAT#: 00-5990-035-10, LOT#: 60308860. FOREIGN: (B)(6). CUSTOMER HAS INDICATED THAT THE PRODUCT WILL NOT BE RETURNED TO ZIMMER BIOMET FOR INVESTIGATION, AS PRODUCT LOCATION IS UNKNOWN. THE INVESTIGATION IS IN PROCESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS. MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT, PLEASE SEE ASSOCIATED REPORTS:0001822565 - 2018 - 00506, 0001822565-2018-00507, 0001822565 - 2018 - 00508, 0001822565-2018-00509. PRODUCT LOCATION IS UNKNOWN.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT WAS REVISED EIGHT YEARS AFTER KNEE ARTHROPLASTY DUE TO FEMORAL CONE FRACTURE AND DISASSOCIATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
83482 NEXGEN FEMORAL AUGMENTS PROSTHESIS, KNEE JWH ZIMMER BIOMET, INC. N/A 61643130

Patients

Seq Age Sex Outcome Treatment
1 69 YR Hospitalization| R